VGXI
History
| Year | Detail |
|---|---|
| 1997 | ADVISYS Inc. was founded as a gene therapy company. |
| 2008 | GeneOne Life Science, Inc. acquired the company, and all manufacturing activities were aligned into VGXI, Inc. |
| 2009 - 2014 | VGXI launched its Highly Documented (HD) plasmid manufacturing service to supply raw material for producing GMP viruses and cell therapies. |
| 2015 - 2019 | VGXI established the Advanced Biopharmaceuticals International Center of Support (ABICS) at its The Woodlands, Texas facility. |
| 2022 | VGXI partnered with Geneos Therapeutics, Inc., to support the expansion of the GT-30 clinical trial, which is focused on treating patients with advanced hepatocellular carcinoma, an aggressive form of liver cancer. |
| 2024 | VGXI partnered with Sutro Biopharma, Inc., to support clinical production of luveltamab tazevibulin, a novel Folate Receptor-α (FRα)-targeting antibody-drug conjugate (ADC) with the potential to address the unmet need in several FRα-expressing cancers. |
BCC Research Beacon 